Rocky Mountain Cancer Centers-Boulder — Boulder, Colorado

Rocky Mountain Cancer Centers-Boulder is a clinical research site located in Boulder, Colorado, United States 80303.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers-Boulder has participated in 217 clinical trials with 134 currently active.

Therapeutic areas: Breast Cancer, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7.

Sponsors: NSABP Foundation Inc, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boulder

Browse all research sites in Colorado · View every site in Boulder

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers-Boulder?

Rocky Mountain Cancer Centers-Boulder has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers-Boulder conducted?

Rocky Mountain Cancer Centers-Boulder has 217 clinical trials on record, with 134 currently active. Their work covers Breast Cancer, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7.

Is Rocky Mountain Cancer Centers-Boulder accredited by Crixeo Clinical Trials?

Rocky Mountain Cancer Centers-Boulder has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers-Boulder?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.